Lilly to Acquire European Rights to Pfizer Animal Health Assets +++ Deal Provides Strategic Fit For Elanco, Lilly’s Animal Health Division
GREENFIELD, Ind., March 8, 2010 /PRNewswire via COMTEX News Network/ — Elanco, the animal health division of Eli Lilly and Company (NYSE: LLY), today announced that Lilly has signed an agreement to acquire the European rights to a portfolio of certain Pfizer Animal Health products. The products, including vaccines, parasiticides and feed additives, are used in both the production animal and companion animal markets.
More ...